Genepoint Technologies Co., Ltd.
PrivateLast Round
Series D
Jan 18, 2023
Total Funding Raised
$67.15M
Company Overview
Genepoint Technologies Co., Ltd. is a biotechnology company that develops and manufactures automated cryogenic storage and handling systems for life sciences research and biobanking.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Warehouse Automation, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genepoint Technologies Co., Ltd. Comparables
Compare Genepoint Technologies Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Origincell Biological Cryo Equipment Co., Ltd. | 89% | |
| Origincell Technology Group | 89% | |
| Shanghai iKelvin Life Science & Technology Co., Ltd. | 85% |
Genepoint Technologies Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 18, 2023 | ||||
| Series C Extension | Feb 7, 2022 | ||||
| Series C Extension | Jul 12, 2021 | ||||
| Series C | Jun 9, 2021 | ||||
| Series B | Oct 31, 2019 | ||||
Series A | Aug 24, 2018 |
Genepoint Technologies Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series D, Series C, Series C Extension |
| Hosencare Brothers | Series C |
| Bangming Capital | Angel |
| Zhongke Guosheng | Series D |
| Day One Capital | Series D, Series C, Series C Extension |
| Northern Light Venture Capital | Series C |
| LYFE Capital | Series D, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 18, 2023
$30M round led by Guofang Capital
- Feb 7, 2022
$19M round led by LYFE Capital, Day One Capital, and DYEE Capital.
Genepoint Technologies Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genepoint Technologies Co., Ltd.'s valuation, stock price, and market status.
Is Genepoint Biological Technology a public or private company?
Genepoint Biological Technology is a private company.
What is the current stock price of Genepoint Biological Technology?
Genepoint Biological Technology is a private company with no public stock price. No recent secondary market data is available.
How much is Genepoint Biological Technology worth (valuation)?
Valuation information for Genepoint Biological Technology is not publicly available.
Can I buy Genepoint Biological Technology stock?
Genepoint Biological Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genepoint Biological Technology's last funding round?
Genepoint Biological Technology's most recent funding round was Series D on January 18, 2023.
Who are the main investors in Genepoint Biological Technology?
Key investors in Genepoint Biological Technology include Bangming Capital, Day One Capital, Northern Light Venture Capital, LYFE Capital, Shanghai Guofang Private Equity Fund Management.
Will Genepoint Biological Technology IPO soon?
No public IPO plans have been announced for Genepoint Biological Technology.
How can I track Genepoint Biological Technology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genepoint Biological Technology's secondary market activity and sign up for updates.